OS. MOZARTA 1/29 31-232 KRAKÓW
(+48) 607 345 792

Services

CENTRUM HTA PROVIDES CONSULTANCY SERVICES CONCERNING PHARMACEUTICAL MARKET ISSUES IN POLAND

THE COMPANY’S ACTIVITY COVERS A WIDE RANGE OF CONSULTANCY SERVICES CONCERNING, IN PARTICULAR: PREPARATION OF REPORTS ON CLINICAL AND ECONOMIC EFFECTIVENESS ASSESSMENT FOR PHARMACEUTICALS AND MEDICAL PRODUCTS.

FULL HTA DOSSIER

  • Decision Problem Analysis
  • Clinical analysis
  • Economic analysis
  • Budget Impact Analysis
  • Rationalization Analysis

CHARACTERISTICS OF THE PHARMACEUTICAL MARKET IN POLAND

REVIEW OF EPIDEMIOLOGICAL AND COST SPECIFIC DATA IN POLISH SETTINGS

SYSTEMATIC REVIEW OF CLINICAL TRIALS

BUDGET IMPACT ANALYSIS FOR GENERIC DRUGS

FULL TEXT PUBLICATIONS

WORKSHOPS
ON EBM AND HTA

ADVISORY BOARD

SCIENTIFIC CONFERENCES MATERIALS

FULL RANGE REIMBURSEMENT CONSULTING

HTA ANALYZES ARE DEVELOPED BY CENTRUM HTA WITH GREAT ACCURACY, FULLY ACCORDING TO THE CURRENT FORMAL REQUIREMENTS IN POLAND.

  • Act of May 12, 2011 on reimbursement of medicines, foodstuffs for particular nutritional purposes and medical devices (as amended)
  • Minimum requirements to be satisfied by the analysis contained in reimbursement application. The English version of Regulation of the Minister Of Health of 2 April 2012 on the minimum requirements to be satisfied by the analyses accounted for in the applications for reimbursement and setting the official sales price and for increasing the official sales price of a drug, a special purpose dietary supplement, a medical device, which do not have a reimbursed counterpart in a given indication
  • Health Technology Assessment Guidelines Version 3.0 Warsaw, August 2016 (publication date 14 of September 2016)